Privi Speciality Chemicals reported FY26 consolidated revenue of ₹2,583 crore, a 22% YoY increase driven by volume growth and improved product mix.
The company generated strong operating cash flow of ₹550 crore, reduced total debt by ₹113 crore, and invested ₹320 crore in CAPEX for debottlenecking and expansion.
Privi outlined its 5k:1k vision targeting ₹5,000 crore revenue and ₹1,000 crore+ EBITDA by FY29-30, with margins expected to sustain above 20%.